2007 to 2023 Saw Decline in Menopausal Hormone Therapy Usage Rates
By Elana Gotkine HealthDay Reporter
TUESDAY, Sept. 10, 2024 -- Menopausal hormone therapy (HT) usage rates declined from 2007 to 2023 and remain low, according to a study presented at the annual meeting of The Menopause Society, held from Sept. 10 to 14 in Chicago.
Mariam Saadedine, M.D., from the Mayo Clinic in Jacksonville, Florida, and colleagues described systemic menopausal HT utilization in women aged 40 years and older between 2007 and 2023 using claims data from the OptumLabs data warehouse. The annual rate of HT utilization was defined as the proportion of women with at least 180 days of a filled prescription for systemic estrogen-containing menopausal HT within one year.
The study population increased from about 2 million in 2007 to 4.5 million in 2023. The researchers found that among women aged 40 years or older, HT use was 4.6 percent in 2007, decreased to 2.5 percent between 2007 and 2014, and continued decreasing, reaching 1.8 percent in 2023. The most common route of administration was oral. HT use decreased from 3.2, 6, and 7.3 percent in 2007 to 1.5, 3.6, and 3.8 percent in 2023 among women aged 45 to 49, 50 to 54, and 55 to 59 years.
"These findings suggest that substantial barriers to HT use remain, and additional efforts are needed to educate women and clinicians about menopause management and HT use more specifically," coauthor Stephanie Faubion, M.D., medical director of The Menopause Society, said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2024
Read this next
Gestational Hypertension Tied to Higher Later Risk for Cardiovascular Disease
MONDAY, Sept. 16, 2024 -- A self-reported history of gestational hypertension is associated with cardiovascular disease (CVD) in postmenopausal women, according to a study...
Hot Flashes May Occur More Often in Second Half of Nightly Sleep
MONDAY, Sept. 16, 2024 -- Hot flashes (HFs) may pose a larger burden during the second half of the night, according to a study presented at the annual meeting of the Menopause...
Hormone Tx Tied to Reductions in Insulin Resistance
WEDNESDAY, Sept. 11, 2024 -- Hormone therapy (HT) is associated with significantly reduced insulin resistance in healthy postmenopausal women, according to a study presented at...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.